首页> 外文期刊>Cardiology >Heart Failure in the Time of COVID-19
【24h】

Heart Failure in the Time of COVID-19

机译:Covid-19时的心力衰竭

获取原文
获取原文并翻译 | 示例
           

摘要

Background:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a new threat to healthcare systems. In this setting, heart failure units have faced an enormous challenge: taking care of their patients while at the same time avoiding patients' visits to the hospital.Objective:The aim of this study was to evaluate the results of a follow-up protocol established in an advanced heart failure unit at a single center in Spain during the coronavirus disease 2019 (COVID-19) pandemic.Methods:During March and April 2020, a protocolized approach was implemented in our unit to reduce the number of outpatient visits and hospital admissions throughout the maximum COVID-19 spread period. We compared emergency room (ER) visits, hospital admissions, and mortality with those of January and February 2020.Results:When compared to the preceding months, during the COVID pandemic there was a 56.5% reduction in the ER visits and a 46.9% reduction in hospital admissions, without an increase in mortality (9 patients died in both time periods). A total of 18 patients required a visit to the outpatient clinic for decompensation of heart failure or others.Conclusion:Our study suggests that implementing an active-surveillance protocol in acutely decompensated heart failure units during the SARS-CoV-2 pandemic can reduce hospital admissions, ER visits and, potentially, viral transmission, in a cohort of especially vulnerable patients.
机译:背景:严重急性呼吸综合征冠状病毒2(SARS-COV-2)已成为对医疗保健系统的新威胁。在这个环境中,心力衰竭单位面临着巨大的挑战:同时照顾患者,避免患者对医院的访问。目的:本研究的目的是评估建立后续协议的结果在西班牙的单一中心的高级心力衰竭单元中,2019年(Covid-19)Pandemic.mantmim.methods:在3月20日和4月2020年4月,我们的单位在我们的单位中实施了,以减少门诊访问和医院入学人数在最大的Covid-19传播期间。我们将急诊室(ER)访问,医院入学和死亡中的死亡率与1月20日和2月相比。结果:与前几个月相比,在Covid流行期间,勘探次数减少了56.5%,减少了46.9%在医院入院,没有死亡率的增加(9名患者在两次死亡时期)。共有18名患者需要访问门诊诊所,以解除心力衰竭或其他患者。结论:我们的研究表明,在SARS-COV-2大流行期间在急性失代偿的心力衰竭单元中实施活跃监测议定书可以减少医院录取,eR访问和,潜在,病毒传播,在尤其是脆弱的患者的队列中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号